Table 3.
Pharmacokinetic characteristics of cannabinoids
| Cannabinoid Compound | Substrate Pathway | Affected Metabolism Pathways | |
|---|---|---|---|
| Inhibitor | Inducer | ||
| Cannabidiol | CYP3A4 CYP2C19 |
CYP3A4 CYP2D6 CYP2C8/9/19 CYP1A1/2 CYP1B1 CYP2B6 |
|
| Tetrahydrocannabinol | CYP2C9 CYP3A4 |
CYP3A CYP2D6 CYP2C9 CYP2B6 |
CYP1A1/2 |
| Cannabinol | CYP2C9 CYP3A4 |
CYP3A CYP2D6 CYP2C9 CYP2B6 |
|
| Synthetic Cannabinoids | CYP2C9 CYP1A2 CYP2D6 |
CYP1A CYP2C8/9/19 CYP3A |
|